Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04730349
Title A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer (PIVOT IO 020)
Acronym PIVOT IO 020
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | ITA | FRA | ESP | DEU | AUS

Facility Status City State Zip Country Details
Local Institution - 0029 Little Rock Arkansas 72202 United States Details
Local Institution - 0011 Saint Louis Missouri 63110 United States Details
Local Institution - 0001 Randwick New South Wales 2031 Australia Details
Local Institution South Brisbane Queensland 4101 Australia Details
Local Institution - 0002 Parkville Victoria 3052 Australia Details
Local Institution - 0003 Perth Western Australia 6009 Australia Details
Local Institution - 0013 Villejuif Val-de-Marne 94805 France Details
Local Institution - 0014 Lyon 69373 cedex 03 France Details
Local Institution - 0016 Marseille 13385 France Details
Local Institution - 0015 Paris 75005 France Details
Local Institution - 0038 Hamburg 20246 Germany Details
Local Institution - 0039 Tuebingen 72076 Germany Details
Local Institution - 0037 Wuerzburg 97080 Germany Details
Local Institution - 0027 Milan 20133 Italy Details
Local Institution - 0009 Madrid Madrid, Comunidad De 28009 Spain Details
Local Institution - 0008 Barcelona 08035 Spain Details
Local Institution - 0059 Sevilla 41013 Spain Details
Local Institution - 0028 València 46026 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field